Everolimus-Induced Systemic Serositis After Simultaneous Liver and Kidney Transplantation: A Case Report

Budde, 2011, Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial, Lancet, 377, 837, 10.1016/S0140-6736(10)62318-5 Budde, 2015, Five-year outcomes in kidney transplant patients converted from cyclosporine to everolimus: the randomized ZEUS study, Am J Transplant, 15, 119, 10.1111/ajt.12952 Flechner, 2011, The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients, Am J Transplant, 11, 1633, 10.1111/j.1600-6143.2011.03573.x Weir, 2011, Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial, Kidney Int, 79, 897, 10.1038/ki.2010.492 Stallone, 2005, Sirolimus for Kaposi's sarcoma in renal-transplant recipients, N Engl J Med, 352, 1317, 10.1056/NEJMoa042831 Euvrard, 2012, Sirolimus and secondary skin-cancer prevention in kidney transplantation, N Engl J Med, 367, 329, 10.1056/NEJMoa1204166 Exposito, 2008, Everolimus-related pulmonary toxicity in heart transplant recipients, J Heart Lung Transplant, 27, 797, 10.1016/j.healun.2008.03.016 Gurk-Turner, 2012, A comprehensive review of everolimus clinical reports: a new mammalian target of rapamycin inhibitor, Transplantation, 94, 659, 10.1097/TP.0b013e31825b411c Steele, 2008, Pericardial effusion coincident with sirolimus therapy: a review of Wyeth's safety database, Transplantation, 85, 645, 10.1097/TP.0b013e3181636061 Truong, 2005, Cardiac tamponade in a pediatric renal transplant recipient on sirolimus therapy, Pediatr Transplant, 9, 541, 10.1111/j.1399-3046.2005.00323.x Bertrand, 2013, Sirolimus therapy may cause cardiac tamponade, Transpl Int, 26, e4, 10.1111/tri.12025 Huber, 2007, Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis, Kidney Int, 71, 771, 10.1038/sj.ki.5002112 Kobayashi, 2007, Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis, Cancer Sci, 98, 726, 10.1111/j.1349-7006.2007.00439.x White, 2010, Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma, Am J Respir Crit Care Med, 182, 396, 10.1164/rccm.200911-1720OC